Zolpidem improves tardive dyskinesia and akathisia

Movement Disorders

Volumn 28, Issue 12, 2013, Pages 1748-1749

  Waln, Olga ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; LEVODOPA; TETRABENAZINE; THIORIDAZINE; TIOTIXENE; TRIHEXYPHENIDYL; ZOLPIDEM;

ADULT; AGED; AKATHISIA; ATAXIA; BLEPHAROSPASM; CASE REPORT; DEPRESSION; DROWSINESS; FEMALE; HUMAN; LETTER; MULTIPLE PERSONALITY; PRIORITY JOURNAL; SUICIDAL IDEATION; TARDIVE DYSKINESIA;

ADULT; AGED; AKATHISIA, DRUG-INDUCED; DYSKINESIA, DRUG-INDUCED; FEMALE; GABA-A RECEPTOR AGONISTS; HUMANS; PYRIDINES; TREATMENT OUTCOME;

EID: 84886381539     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25480     Document Type: Letter

References (6)

1. Jankovic J, Clarence-Smith K. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev Neurother 2011;11:1509-1523.
2. Bhidayasiri R, Boonyawairoj S. Spectrum of tardive syndromes: clinical recognition and management. Postgrad Med J 2011;87:132-141.
3. Tamminga CA, Thaker GK, Chase TN. GABA dysfunction in the pathophysiology of tardive dyskinesia. Psychopharmacol Suppl 1985;2:122-127.
4. Teo JT, Edwards MJ, Bhatia K. Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis. Mov Disord 2012;27:1205-1215.
5. Bishnoi M, Chopra K, Kulkarni SK. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1130-1138.
6. Park IS, Kim JS, An JY, Kim YI, Lee SK. Excellent response to oral zolpidem in a sporadic case of the myoclonus dystonia syndrome. Mov Disord 2009;24:2172-2173.